Brief Report: Informing Strategies to Build PrEP Capacity Among San Francisco Bay Area Clinicians

Overview

Journal J Acquir Immune Defic Syndr

Specialty Infectious Diseases

Date 2016 Sep 23

PMID 27654813

Citations 23

Authors

Oliver Bacon

Rafael Gonzalez

Erin Andrew

Michael B Potter

James R Iniguez

Stephanie E Cohen

Albert Y Liu

Jonathan D Fuchs

Affiliations

Soon will be listed here.

Abstract

A large pool of clinicians are needed to meet the growing demand for HIV preexposure prophylaxis. We surveyed a mixed group of HIV specialists and nonspecialists in the San Francisco Bay Area to determine their attitudes toward and training needs regarding prescribing preexposure prophylaxis to persons at increased risk of HIV infection. Willingness to prescribe was associated with experience in caring for HIV-infected patients (adjusted odds ratio 4.76, 95% confidence interval: 1.43 to 15.76, P = 0.01). Desire for further training was associated with concerns about drug resistance (P = 0.04) and side effects (P = 0.04) and was more common among noninfectious disease specialists. Clinicians favored online and in-person training methods.

Citing Articles

Barriers and Opportunities to Improve the Implementation of Patient Screening and Linkage to Pre-Exposure Prophylaxis in Primary Care.

Nacht C, Felner J, Muthuramalingam S, Towner W, Ling Grant D, Martos A J Clin Res HIV AIDS Prev. 2023; 4(2):15-31.

PMID: 37841674 PMC: 10572105. DOI: 10.14302/issn.2324-7339.jcrhap-22-4371.

Usability and Utility of Human Immunodeficiency Virus Pre-exposure Prophylaxis Clinical Decision Support to Increase Knowledge and Pre-exposure Prophylaxis Initiations among Pediatric Providers.

Chan C, Carlson J, Lee T, Vo M, Nasr A, Hart-Cooper G Appl Clin Inform. 2022; 13(5):1141-1150.

PMID: 36351546 PMC: 9731791. DOI: 10.1055/a-1975-4277.

Applying implementation science frameworks to identify factors that influence the intention of healthcare providers to offer PrEP care and advocate for PrEP in HIV clinics in Colombia: a cross-sectional study.

Martinez-Cajas J, Torres J, Mueses H, Camargo Plazas P, Arrivillaga M, Gomez S Implement Sci Commun. 2022; 3(1):31.

PMID: 35296369 PMC: 8925047. DOI: 10.1186/s43058-022-00278-2.

Implementation of HIV pre-exposure prophylaxis for women of color: Perspectives from healthcare providers and staff from three clinical settings.

Kimmel A, Messersmith L, Bazzi A, Sullivan M, Boudreau J, Drainoni M J HIV AIDS Soc Serv. 2021; 19(4):299-319.

PMID: 34456637 PMC: 8386511. DOI: 10.1080/15381501.2021.1887038.

Recommendations for Increasing Physician Provision of Pre-Exposure Prophylaxis: Implications for Medical Student Training.

Cooper R, Juarez P, Morris M, Ramesh A, Edgerton R, Brown L Inquiry. 2021; 58:469580211017666.

PMID: 34027712 PMC: 8142521. DOI: 10.1177/00469580211017666.

References

Hoffman S, Guidry J, Collier K, Mantell J, Boccher-Lattimore D, Kaighobadi F . A Clinical Home for Preexposure Prophylaxis: Diverse Health Care Providers' Perspectives on the "Purview Paradox". J Int Assoc Provid AIDS Care. 2015; 15(1):59-65. PMC: 4703503. DOI: 10.1177/2325957415600798. View

Thigpen M, Rose C, Paxton L . Antiretroviral preexposure prophylaxis for HIV prevention. N Engl J Med. 2013; 368(1):82-3. DOI: 10.1056/NEJMc1210464. View

Grant R, Lama J, Anderson P, McMahan V, Liu A, Vargas L . Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010; 363(27):2587-99. PMC: 3079639. DOI: 10.1056/NEJMoa1011205. View

Kim C, Vasaiwala S, Haque F, Pratap K, Vidovich M . Radiation safety among cardiology fellows. Am J Cardiol. 2010; 106(1):125-8. DOI: 10.1016/j.amjcard.2010.02.026. View

Krakower D, Mayer K . The role of healthcare providers in the roll out of preexposure prophylaxis. Curr Opin HIV AIDS. 2015; 11(1):41-8. PMC: 4676563. DOI: 10.1097/COH.0000000000000206. View

Avorn J, Soumerai S . Improving drug-therapy decisions through educational outreach. A randomized controlled trial of academically based "detailing". N Engl J Med. 1983; 308(24):1457-63. DOI: 10.1056/NEJM198306163082406. View

Smith D, Mendoza M, Stryker J, Rose C . PrEP Awareness and Attitudes in a National Survey of Primary Care Clinicians in the United States, 2009-2015. PLoS One. 2016; 11(6):e0156592. PMC: 4892482. DOI: 10.1371/journal.pone.0156592. View

Liu A, Cohen S, Vittinghoff E, Anderson P, Doblecki-Lewis S, Bacon O . Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services. JAMA Intern Med. 2015; 176(1):75-84. PMC: 5042323. DOI: 10.1001/jamainternmed.2015.4683. View

Smith D, Van Handel M, Wolitski R, Stryker J, Hall H, Prejean J . Vital Signs: Estimated Percentages and Numbers of Adults with Indications for Preexposure Prophylaxis to Prevent HIV Acquisition--United States, 2015. MMWR Morb Mortal Wkly Rep. 2015; 64(46):1291-5. DOI: 10.15585/mmwr.mm6446a4. View

10.

Volk J, Marcus J, Phengrasamy T, Blechinger D, Nguyen D, Follansbee S . No New HIV Infections With Increasing Use of HIV Preexposure Prophylaxis in a Clinical Practice Setting. Clin Infect Dis. 2015; 61(10):1601-3. PMC: 4809999. DOI: 10.1093/cid/civ778. View

11.

Nicholls K, Chapman K, Shaw T, Perkins A, Sullivan M, Crutchfield S . Enhancing response rates in physician surveys: the limited utility of electronic options. Health Serv Res. 2011; 46(5):1675-82. PMC: 3207199. DOI: 10.1111/j.1475-6773.2011.01261.x. View

12.

VanGeest J, Johnson T, Welch V . Methodologies for improving response rates in surveys of physicians: a systematic review. Eval Health Prof. 2007; 30(4):303-21. DOI: 10.1177/0163278707307899. View

13.

Berwick D . Disseminating innovations in health care. JAMA. 2003; 289(15):1969-75. DOI: 10.1001/jama.289.15.1969. View

14.

Grohskopf L, Chillag K, Gvetadze R, Liu A, Thompson M, Mayer K . Randomized trial of clinical safety of daily oral tenofovir disoproxil fumarate among HIV-uninfected men who have sex with men in the United States. J Acquir Immune Defic Syndr. 2013; 64(1):79-86. DOI: 10.1097/QAI.0b013e31828ece33. View

15.

Braithwaite D, Emery J, de Lusignan S, Sutton S . Using the Internet to conduct surveys of health professionals: a valid alternative?. Fam Pract. 2003; 20(5):545-51. DOI: 10.1093/fampra/cmg509. View

16.

Cohen S, Vittinghoff E, Bacon O, Doblecki-Lewis S, Postle B, Feaster D . High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project. J Acquir Immune Defic Syndr. 2014; 68(4):439-48. PMC: 4334721. DOI: 10.1097/QAI.0000000000000479. View

17.

Liu A, Cohen S, Follansbee S, Cohan D, Weber S, Sachdev D . Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014; 11(3):e1001613. PMC: 3942317. DOI: 10.1371/journal.pmed.1001613. View

18.

Krakower D, Oldenburg C, Mitty J, Wilson I, Kurth A, Maloney K . Knowledge, Beliefs and Practices Regarding Antiretroviral Medications for HIV Prevention: Results from a Survey of Healthcare Providers in New England. PLoS One. 2015; 10(7):e0132398. PMC: 4492498. DOI: 10.1371/journal.pone.0132398. View

19.

Baeten J, Donnell D, Ndase P, Mugo N, Campbell J, Wangisi J . Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012; 367(5):399-410. PMC: 3770474. DOI: 10.1056/NEJMoa1108524. View